A detailed history of Capital Investment Advisory Services, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Capital Investment Advisory Services, LLC holds 2,439 shares of BNTX stock, worth $289,119. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,439
Holding current value
$289,119
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$78.36 - $124.66 $191,120 - $304,045
2,439 New
2,439 $289,000
Q3 2023

Nov 02, 2023

BUY
$98.5 - $125.08 $304,266 - $386,372
3,089 New
3,089 $335,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Capital Investment Advisory Services, LLC Portfolio

Follow Capital Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.